## FDA approves new drug for the prevention of migraine ## Th | Golden pharma
## FDA approves new drug for the prevention of migraine ##
The FDA has approved atogepant(Qulipta) for the prevention of episodic migraine. The once daily medication will be available in doses of 10mg, 30mg and 60mg.
Atogepant is a calcitonin gene related peptide(CGRP) antagonist. It targets CGRP, which is involved in migraine development.
@Ethiomedicalconsultancy #Join#us#for#more Medical videos, Scientific tips, Medical books, Medical journals and Interesting case discussions
we provide medical consultaion... medicine and we discuss cases 📚📖📔... and we give Medical advice💉 to the public by the specific proffesionals👩⚕👨⚕. Contact admin: @DrMelsh ...